Literature DB >> 3979659

Ibuprofen: plasma concentrations in man.

G M Janssen, J F Venema.   

Abstract

The plasma levels of ibuprofen were measured in five healthy subjects who took 600 mg tablets of ibuprofen twice daily, three times daily and four times daily in a crossover study. Peak plasma levels were obtained 1 hour after the first dose in all but one subject (slow absorber), the mean peak value being 51.3 micrograms X ml-1 (range 39.4-63.7 micrograms X ml-1). After the repeated dose regimens of two, three or four times daily of ibuprofen, the peak levels achieved were in a similar range to those seen after the first dose: Twice daily 39.4-66.4 micrograms X ml-1; Three times daily 43.6-63.3 micrograms X ml-1; Four times daily 44.1-58.4 micrograms X ml-1. There was no evidence of accumulation of the drug and no side-effects occurred during the trial.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3979659     DOI: 10.1177/030006058501300110

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  14 in total

Review 1.  Clinical pharmacokinetics of ibuprofen. The first 30 years.

Authors:  N M Davies
Journal:  Clin Pharmacokinet       Date:  1998-02       Impact factor: 6.447

2.  Ibuprofen and diclofenac treatments reduce proliferation of pancreatic acinar cells upon inflammatory injury and mitogenic stimulation.

Authors:  Marta Bombardo; Ermanno Malagola; Rong Chen; Alina Rudnicka; Rolf Graf; Sabrina Sonda
Journal:  Br J Pharmacol       Date:  2017-06-16       Impact factor: 8.739

3.  Ibuprofen inhibits key genes involved in androgen production in theca-interstitial cells.

Authors:  Chelsea W Fox; Lingzhi Zhang; Benjamin C Moeller; V Gabriel Garzo; R Jeffrey Chang; Antoni J Duleba
Journal:  F S Sci       Date:  2021-06-30

4.  Pharmacokinetics of S(+)- and R(-)-ibuprofen in volunteers and first clinical experience of S(+)-ibuprofen in rheumatoid arthritis.

Authors:  G Geisslinger; O Schuster; K P Stock; D Loew; G L Bach; K Brune
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

5.  Ligand binding to the FA3-FA4 cleft inhibits the esterase-like activity of human serum albumin.

Authors:  Paolo Ascenzi; Loris Leboffe; Alessandra di Masi; Viviana Trezza; Gabriella Fanali; Magda Gioia; Massimo Coletta; Mauro Fasano
Journal:  PLoS One       Date:  2015-03-19       Impact factor: 3.240

6.  Enhanced longevity by ibuprofen, conserved in multiple species, occurs in yeast through inhibition of tryptophan import.

Authors:  Chong He; Scott K Tsuchiyama; Quynh T Nguyen; Ekaterina N Plyusnina; Samuel R Terrill; Sarah Sahibzada; Bhumil Patel; Alena R Faulkner; Mikhail V Shaposhnikov; Ruilin Tian; Mitsuhiro Tsuchiya; Matt Kaeberlein; Alexey A Moskalev; Brian K Kennedy; Michael Polymenis
Journal:  PLoS Genet       Date:  2014-12-18       Impact factor: 5.917

7.  Effects of Exposure to Acetaminophen and Ibuprofen on Fetal Germ Cell Development in Both Sexes in Rodent and Human Using Multiple Experimental Systems.

Authors:  Pablo Hurtado-Gonzalez; Richard A Anderson; Joni Macdonald; Sander van den Driesche; Karen Kilcoyne; Anne Jørgensen; Chris McKinnell; Sheila Macpherson; Richard M Sharpe; Rod T Mitchell
Journal:  Environ Health Perspect       Date:  2018-04-16       Impact factor: 9.031

8.  Ibuprofen inhibited migration of skeletal muscle cells in association with downregulation of p130cas and CrkII expressions.

Authors:  Chih-Hao Liao; Li-Ping Lin; Tung-Yang Yu; Chih-Chin Hsu; Jong-Hwei S Pang; Wen-Chung Tsai
Journal:  Skelet Muscle       Date:  2019-08-29       Impact factor: 4.912

9.  Your mother was right, washing matters: An alkyne-analog of ibuprofen reveals unwanted reactivity of aromatic compounds with proteins during copper-catalyzed click chemistry.

Authors:  Giuliano Cutolo; Sahiti N Shankar; Matthew R Pratt
Journal:  Bioorg Med Chem Lett       Date:  2021-07-13       Impact factor: 2.940

10.  Rapid exposure of macrophages to drugs resolves four classes of effects on the leading edge sensory pseudopod: Non-perturbing, adaptive, disruptive, and activating.

Authors:  Thomas C Buckles; Brian P Ziemba; Danijel Djukovic; Joseph J Falke
Journal:  PLoS One       Date:  2020-05-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.